Molecular Medicine and Biomedical Research in the Era of Precision Medicine: New Technologies and Personalized Drug Therapies for Patient Care
Editat de Ranbir Chander Sobti, Douglas W Wilson, Harpal S Buttar, Istvan G Telessy, Aastha Sobtien Limba Engleză Paperback – mar 2025
The book also tackles targeted treatments of different disease types, including acute, chronic, infectious and noncommunicable diseases. Future perspectives are also covered, providing an in-depth study across molecular medicine, drug discovery and delivery, disease diagnosis and prevention, and therapeutic interventions, and acting as an invaluable interdisciplinary reference for researchers across the biomedical sciences.
- Investigates the molecular basis and mechanisms of diseases, including cardiovascular, infectious, and neurological diseases
- Presents molecular-based therapeutics for personalized treatment and the diagnosis of various conditions
- Considers a range of technologies in the field of biomedicine and molecular medicine, including artificial intelligence and nanotechnology
Preț: 1165.54 lei
Preț vechi: 1540.41 lei
-24% Nou
Puncte Express: 1748
Preț estimativ în valută:
223.08€ • 232.51$ • 185.71£
223.08€ • 232.51$ • 185.71£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443223006
ISBN-10: 0443223009
Pagini: 600
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0443223009
Pagini: 600
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
Section I: Introduction to molecular medicine, drug discovery and drug delivery, and their roles in biomedical sciences Introduction and Preface
Section II: Technologies in biomedicine and molecular medicine
A: Basic and emerging technologies
1. Single-cell RNA-seq technologies in biomedical studies and their potential clinical applications
2. Next-generation sequencing (NGS), OMICS and gene editing technologies: Their role in biomedical sciences
3. Artificial intelligence in molecular medicine
4. Role of modern scientific technologies and innovations for augmenting health care and precision in health care system
5. Machine Learning in the field of health care using medical images
6. Role of computer assisted prediction models in disease prevention
7. Physiological studies on the usefulness of chips
8. Bioinformatics as a tool for biomedical innovations
9. Molecular Epidemiological approach in disease management
10. Novel aspects of personalized medicines, patient care and management
11. Stem cells and Gene Therapy in disease management
12. Role of telemedicine in point of care treatment of patients
B: Application of technology in some diseases
13. Machine learning based data modeling for heart disease prediction
14. Computational biomedical sciences for renal disease management
15. Impact of machine learning in the prediction and prevention of neurological diseases.
16. Telemedicine and internet-based advice to pregnant and nursing mothers
17. Effectiveness of telemedicine and internet-based diagnosis for the prevention of adverse drug effects (ADRs).
18. Harvesting and growing of stem cells for regenerative medicine with special reference to dermal disorders
19. Nanotechnology innovations for targeted delivery of multiple drugs in cancer patients
20. Development of prolonged drug delivery systems for the treatment of chronic diseases
21. Gold nanoparticles: A promising molecular probe for diagnostic purposes, discovery of new therapies, cure for certain cancers, as well as gene carriers and drug delivery vehicles
22. Impact of circadian rhythms in neurological disorders, cardiovascular diseases, and diabetes mellitus
23. Role of Omics and metabolomics in drug discovery and drug delivery in biomedical sciences
24. Pharmacogenetics in drug dose adjustments in the pediatric and elderly populations
25. Impact of lifestyle factors on cognitive function in older adults (> 60 yrs.) and detection by apolipoprotein E genotyping.
Section III: Interventions and treatments across disease types
A: Role of microbiota in diseases
26. Pivotal role of healthy gut microbiota in the prevention of non-communicable diseases (NCDs)
27. Emerging role of gut microbiomes in immunomodulation and colorectal cancer
28. Influence of the gut microbiomes on cardiovascular health and hypertension
29. Role of probiotics, prebiotics and symbiotic in the improvement of gut microflora
30. Genetic, cellular and molecular biology germane to cardiovascular ailments (e.g., coronary heart disease and stroke) and neurological diseases (e.g., dementia, Alzheimer disease) in the ageing population
31. Molecular biology of chronic heart failure: Prevention and management by antioxidant and anti-inflammation foods and phytotherapies
32. Therapeutic applications of human and bovine colostrum: Underlying mechanisms of action
B: Challenges and interventions in NCDs
33. Environmental impact on cardiorespiratory and kidney related diseases
34. Pathophysiology of coronary heart disease: Role of the renin-angiotensin and aldosterone system
35. Emerging respiratory problems including chronic obstructive pulmonary disease (COPD)
36. Stroke: Causes, diagnosis and management by cholesterol lowering agents and other suitable medicines
C: Challenges and interventions in infectious diseases
37. Emerging and re-emerging infectious diseases and challenges ahead
38. Tuberculosis: Molecular aspects in prediction, diagnosis and treatment
39. Viral hepatitis: its occurrence, diagnosis and management
40. Monkey pox and its impact on human health
41. Prophylactic vaccination strategies for the prevention of microbial diseases with particular reference to COVID-19 on public health and health care system
Section IV: Molecular medicine and nutrition
42. Clinical Nutrition in health promotion and well-being
43. Influence of nutraceuticals in health promotion and disease prevention
44. Biochemical, biophysical and therapeutic properties of functional foods and Mediterranean diet
45. Traditional and novel fermented foods in the prevention of non-communicable diseases (NCDs)
46. Clinical implications and mechanism of drug-drug and drug-food-herbal interactions
???????Section V: Targeted therapies and strategies for the treatment of acute and chronic diseases
47. Emerging trends in drug delivery systems: Scope and challenges
48. Role of Nanotechnology in the targeted delivery of anticancer drugs
49. Impact of Phamacometabolomics in new drug discovery and development of novel therapies for the management of NCDs
50. Drug dose adjustment in elderly population using polypharmacy for co-morbid conditions
51. Safety and efficacy assessment of new vaccines and their development
52. Antibiotic resistance and development alternative therapies
53. Drug regulatory requirements by the drug regulatory agencies
54. Post-marketing surveillance of drugs for monitoring adverse drug reaction (ADRs)
55. Ethical issues and challenges in biomedical research
Section VI: Future perspectives in the development of novel technologies in biomedicine and molecular medicine
Section II: Technologies in biomedicine and molecular medicine
A: Basic and emerging technologies
1. Single-cell RNA-seq technologies in biomedical studies and their potential clinical applications
2. Next-generation sequencing (NGS), OMICS and gene editing technologies: Their role in biomedical sciences
3. Artificial intelligence in molecular medicine
4. Role of modern scientific technologies and innovations for augmenting health care and precision in health care system
5. Machine Learning in the field of health care using medical images
6. Role of computer assisted prediction models in disease prevention
7. Physiological studies on the usefulness of chips
8. Bioinformatics as a tool for biomedical innovations
9. Molecular Epidemiological approach in disease management
10. Novel aspects of personalized medicines, patient care and management
11. Stem cells and Gene Therapy in disease management
12. Role of telemedicine in point of care treatment of patients
B: Application of technology in some diseases
13. Machine learning based data modeling for heart disease prediction
14. Computational biomedical sciences for renal disease management
15. Impact of machine learning in the prediction and prevention of neurological diseases.
16. Telemedicine and internet-based advice to pregnant and nursing mothers
17. Effectiveness of telemedicine and internet-based diagnosis for the prevention of adverse drug effects (ADRs).
18. Harvesting and growing of stem cells for regenerative medicine with special reference to dermal disorders
19. Nanotechnology innovations for targeted delivery of multiple drugs in cancer patients
20. Development of prolonged drug delivery systems for the treatment of chronic diseases
21. Gold nanoparticles: A promising molecular probe for diagnostic purposes, discovery of new therapies, cure for certain cancers, as well as gene carriers and drug delivery vehicles
22. Impact of circadian rhythms in neurological disorders, cardiovascular diseases, and diabetes mellitus
23. Role of Omics and metabolomics in drug discovery and drug delivery in biomedical sciences
24. Pharmacogenetics in drug dose adjustments in the pediatric and elderly populations
25. Impact of lifestyle factors on cognitive function in older adults (> 60 yrs.) and detection by apolipoprotein E genotyping.
Section III: Interventions and treatments across disease types
A: Role of microbiota in diseases
26. Pivotal role of healthy gut microbiota in the prevention of non-communicable diseases (NCDs)
27. Emerging role of gut microbiomes in immunomodulation and colorectal cancer
28. Influence of the gut microbiomes on cardiovascular health and hypertension
29. Role of probiotics, prebiotics and symbiotic in the improvement of gut microflora
30. Genetic, cellular and molecular biology germane to cardiovascular ailments (e.g., coronary heart disease and stroke) and neurological diseases (e.g., dementia, Alzheimer disease) in the ageing population
31. Molecular biology of chronic heart failure: Prevention and management by antioxidant and anti-inflammation foods and phytotherapies
32. Therapeutic applications of human and bovine colostrum: Underlying mechanisms of action
B: Challenges and interventions in NCDs
33. Environmental impact on cardiorespiratory and kidney related diseases
34. Pathophysiology of coronary heart disease: Role of the renin-angiotensin and aldosterone system
35. Emerging respiratory problems including chronic obstructive pulmonary disease (COPD)
36. Stroke: Causes, diagnosis and management by cholesterol lowering agents and other suitable medicines
C: Challenges and interventions in infectious diseases
37. Emerging and re-emerging infectious diseases and challenges ahead
38. Tuberculosis: Molecular aspects in prediction, diagnosis and treatment
39. Viral hepatitis: its occurrence, diagnosis and management
40. Monkey pox and its impact on human health
41. Prophylactic vaccination strategies for the prevention of microbial diseases with particular reference to COVID-19 on public health and health care system
Section IV: Molecular medicine and nutrition
42. Clinical Nutrition in health promotion and well-being
43. Influence of nutraceuticals in health promotion and disease prevention
44. Biochemical, biophysical and therapeutic properties of functional foods and Mediterranean diet
45. Traditional and novel fermented foods in the prevention of non-communicable diseases (NCDs)
46. Clinical implications and mechanism of drug-drug and drug-food-herbal interactions
???????Section V: Targeted therapies and strategies for the treatment of acute and chronic diseases
47. Emerging trends in drug delivery systems: Scope and challenges
48. Role of Nanotechnology in the targeted delivery of anticancer drugs
49. Impact of Phamacometabolomics in new drug discovery and development of novel therapies for the management of NCDs
50. Drug dose adjustment in elderly population using polypharmacy for co-morbid conditions
51. Safety and efficacy assessment of new vaccines and their development
52. Antibiotic resistance and development alternative therapies
53. Drug regulatory requirements by the drug regulatory agencies
54. Post-marketing surveillance of drugs for monitoring adverse drug reaction (ADRs)
55. Ethical issues and challenges in biomedical research
Section VI: Future perspectives in the development of novel technologies in biomedicine and molecular medicine